Overview of Glp 1 Analogues As A Complementary Therapy In Patients After Metabolic

The evidence is strong that bariatric surgery is superior to medical treatment in terms of weight loss and comorbidities in patients with severe obesity. However, a considerable part of patients presents with unsatisfactory response in the long term. It remains unclear whether postoperative administration of glucagon-like peptide-1 analogues can promote additional benefits. Therefore, a ...

Thus, the use of GLP-1 analogues in addition to surgery promises good results concerning weight loss and improvements of comorbidities and can be used in patients with unsatisfactory results after ...
Key Details About Glp 1 Analogues As A Complementary Therapy In Patients After Metabolic

The papers reviewed revealed that GLP-1 analogues may have beneficial effects on additional weight loss and T2D remission postoperatively. Thus, the use of GLP-1 analogues in addition to surgery promises good results concerning weight loss and improvements of comorbidities and can be used in patients with unsatisfactory results after bariatric ...
It remains unclear whether postoperative administration of glucagon-like peptide-1 analogues can promote additional benefits. Therefore, a systematic review of the current literature on the management of postoperative GLP-1 analogue usage after metabolic surgery was performed.

Mechanisms by which GLP
GLP-1 , glucagon-like peptide-1; GIT, gastrointestinal tract from publication: GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative ...
Metabolic surgery remains the safest, most effective, and most durable option for severe obesity, with GLP-1 therapy serving as a complementary strategy." Dr. Zandvakili agreed, noting that weight-loss-tailored postoperative GLP-1 therapy may be most beneficial to patients with lower blood levels of GLP-1 hormone, including individuals with ...

Safety and efficacy of glucagon
Weight regain and insufficient weight loss are major challenges after metabolic bariatric surgery (MBS), affecting patients' comorbidities and quality of life. The current systematic review and meta-analysis aim to assess the efficacy and safety of GLP-1 receptor agonists ( GLP-1 RA) in patients with weight regain or insufficient weight loss ...
Metabolic and bariatric surgery (MBS) is a successful surgical option for obesity. However, many patients can experience insufficient weight loss and weight regain post-operatively. Glucagon-like peptide-1 ( GLP-1 ) receptor agonists have become available for effective weight loss treatment due to the …

Cardioprotective benefits of metabolic surgery and GLP
Glucagon-like peptide 1 ( GLP-1 ) receptor agonists ( GLP -1RAs) are a class of medication that effectively reduce body weight and MACE in patients with T2DM. This review explores the potential mechanisms underlying the cardioprotective benefits of metabolic surgery and GLP -1RA-based therapies and discusses recent evidence and emerging therapies in ...






Glucagon-like peptide 1 receptor agonists ( GLP-1 RAs) have surfaced as a promising therapeutic avenue. Recognizing the potential of GLP-1 RAs in addressing relapse among individuals who have undergone BS is imperative for enhancing patient outcomes.